Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus.

Diabetes Mellitus, Type 1 / drug therapy Diabetes Mellitus, Type 2 / drug therapy Genetic Predisposition to Disease Glycemic Control Humans Insulin / genetics Polymorphism, Single Nucleotide Receptor, Insulin / genetics
anti-insulin antibodies (IAs) single nucleotide polymorphisms (SNPs) diabetes glycaemic control insulin receptor

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Jun 2022
Historique:
received: 18 05 2022
revised: 05 06 2022
accepted: 08 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Single nucleotide polymorphisms (SNPs) in insulin and insulin receptor genes may influence the interaction between the two molecules, as may anti-insulin antibodies (IAs), commonly found in patients with type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D) treated with exogenous insulin. We examined the impact of two SNPs in the human insulin gene (

Identifiants

DOI: 10.3390/ijms23126481 PMID: 35742925 PMC: PMC9223446
pubmed: 35742925
pii: ijms23126481
doi: 10.3390/ijms23126481
pmc: PMC9223446
pii:
doi:

Substances chimiques

Insulin 0
Receptor, Insulin EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Innovation Fund Denmark
ID : 5189-00147B

Références

Nat Genet. 2009 Jun;41(6):703-7
pubmed: 19430480
Pediatr Diabetes. 2011 Mar;12(2):78-84
pubmed: 20522172
J Diabetes Res. 2013;2013:452537
pubmed: 23671871
Cell Metab. 2018 Dec 4;28(6):922-934.e4
pubmed: 30174303
J Diabetes. 2019 Jun;11(6):484-496
pubmed: 30456822
Pediatr Diabetes. 2018 May;19(3):346-353
pubmed: 29094512
Diabetes Care. 2010 Sep;33(9):2062-4
pubmed: 20805278
Diabetes. 1990 Dec;39(12):1479-84
pubmed: 1978826
Mol Genet Genomics. 2016 Feb;291(1):205-16
pubmed: 26251103
Genes Immun. 2011 Apr;12(3):208-12
pubmed: 21270831
Diabetes Care. 2002 May;25(5):876-82
pubmed: 11978684
Physiol Rev. 2011 Jan;91(1):79-118
pubmed: 21248163
Pediatr Diabetes. 2011 Mar;12(2):75-7
pubmed: 21352424
Nature. 2010 Oct 28;467(7319):1061-73
pubmed: 20981092
Diabetologia. 2011 Jul;54(7):1684-92
pubmed: 21484216
Am J Hum Genet. 1994 Dec;55(6):1247-54
pubmed: 7977386
BMC Nephrol. 2021 Jun 2;22(1):206
pubmed: 34078303
EMBO J. 1989 Sep;8(9):2509-17
pubmed: 2573522
Mol Cell Biochem. 2011 Mar;349(1-2):187-93
pubmed: 21113646
Diabetes. 2008 May;57(5):1433-7
pubmed: 18310307
Methods Mol Biol. 2009;578:23-39
pubmed: 19768585
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Front Endocrinol (Lausanne). 2013 Mar 27;4:37
pubmed: 23542897
Diabetes. 2017 Dec;66(12):2940-2941
pubmed: 29162735
Diabetes. 1994 Jan;43(1):143-53
pubmed: 7505243
Diabetologia. 2012 Mar;55(3):636-43
pubmed: 22186981
Endocr Rev. 2009 Oct;30(6):586-623
pubmed: 19752219
J Immunol. 2017 Mar 1;198(5):1910-1920
pubmed: 28115529
Front Endocrinol (Lausanne). 2014 Jun 19;5:95
pubmed: 24995000
Endocr Rev. 2007 Oct;28(6):625-52
pubmed: 17785428
Cureus. 2020 Jul 15;12(7):e9199
pubmed: 32821554
Diabet Med. 2015 Jul;32(7):843-52
pubmed: 25601320
J Clin Endocrinol Metab. 1999 Mar;84(3):1002-6
pubmed: 10084586
J Autoimmun. 2015 Jul;61:45-53
pubmed: 26074154
Nature. 1980 Mar 6;284(5751):26-32
pubmed: 6243748
PLoS One. 2014 Oct 02;9(10):e109109
pubmed: 25275650
Front Physiol. 2019 Mar 26;10:320
pubmed: 30971952
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14840-5
pubmed: 25267644
Diabetes Technol Ther. 2018 Feb;20(2):160-170
pubmed: 29355435
Diabetes Care. 1990 Mar;13(3):257-79
pubmed: 1968373
N Z Med J. 2012 Sep 21;125(1362):70-80
pubmed: 23178606
Diabetes Care. 2017 Sep;40(9):1194-1202
pubmed: 28646072
Biotechniques. 1993 Oct;15(4):636-8, 640-1
pubmed: 8251166
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31974565
J Clin Endocrinol Metab. 2005 Feb;90(2):1137-43
pubmed: 15562019
Health Promot Perspect. 2020 Mar 30;10(2):98-115
pubmed: 32296622
Annu Rev Med. 1991;42:373-9
pubmed: 2035982
Diabetes. 1991 Jun;40(6):777-82
pubmed: 2040394
J Diabetes Res. 2015;2015:485132
pubmed: 26273670
J Clin Invest. 1990 Jul;86(1):254-64
pubmed: 2365819
J Neuroimmunol. 2009 Jul 25;212(1-2):125-31
pubmed: 19450885
Proc Natl Acad Sci U S A. 1989 Jan;86(1):114-8
pubmed: 2911561
Diabetes. 2007 Aug;56(8):2028-35
pubmed: 17563065
Genes Immun. 2009 Dec;10 Suppl 1:S74-84
pubmed: 19956106
Diabetes Metab Res Rev. 2001 Sep-Oct;17(5):363-73
pubmed: 11747141
N Engl J Med. 2008 Nov 20;359(21):2208-19
pubmed: 19020323
Biochem Biophys Res Commun. 2003 Sep 26;309(3):572-7
pubmed: 12963028
Diabetes Care. 2015 Feb;38(2):308-15
pubmed: 25510400
Diabetologia. 1991 Dec;34(12):848-61
pubmed: 1663881
Lancet. 2014 Mar 22;383(9922):1068-83
pubmed: 24315620

Auteurs

Laura Massarenti (L)

Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Copenhagen University Hospital, Rigshospitalet, 2200 Copenhagen, Denmark.

Christina Aniol-Nielsen (C)

Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Copenhagen University Hospital, Rigshospitalet, 2200 Copenhagen, Denmark.
Clinical Immunogenicity Analysis, Novo Nordisk A/S, 2760 Måløv, Denmark.

Christian Enevold (C)

Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Copenhagen University Hospital, Rigshospitalet, 2200 Copenhagen, Denmark.

Henrik Toft-Hansen (H)

Immunogenicity Assay Development, Novo Nordisk A/S, 2760 Måløv, Denmark.

Claus Henrik Nielsen (CH)

Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Copenhagen University Hospital, Rigshospitalet, 2200 Copenhagen, Denmark.
Section for Oral Biology and Immunopathology, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
ORCID: 0000-0001-7543-9016

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Diabète de type 1 › Influence of Insulin Receptor Single...
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète de type 2 › Influence of Insulin Receptor Single...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Prédisposition génétique à une maladie › Influence of Insulin Receptor Single...
questionsmedicales.fr › Thérapeutique › Régulation de la glycémie › Influence of Insulin Receptor Single...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Influence of Insulin Receptor Single...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones pancréatiques › Insulines › Insuline › Influence of Insulin Receptor Single...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Polymorphisme de nucléotide simple › Influence of Insulin Receptor Single...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormone pancréatique › Récepteur à l'insuline › Influence of Insulin Receptor Single...